Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Recurrent Clostridium difficile enterocolitis].

B Bergamin¹, T Hess, R Jost

¹Medizinische Klinik, Kantonsspital Winterthur.

Schweizerische Medizinische Wochenschrift

|December 5, 2000

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Is the rate of chest computed tomography different between adult and pediatric Level 1 trauma centers?

The journal of trauma and acute care surgery·2026

Same author

Lighting up PNETs: Creating Murine Models with a Novel Bioluminescent Cell Line.

Annals of surgical oncology·2026

Same author

Surgical Stabilization of Rib Fractures in Geriatric Trauma Patients: A National Trauma Data Bank Review.

Journal of the American Geriatrics Society·2026

Same author

A Single-Center Review of Renal Replacement Therapy in Patients With Acute Traumatic Brain Injury.

Cureus·2026

Same author

Use of Whole Blood in Trauma Patients on Anticoagulation or Antiplatelet Therapy.

The Journal of surgical research·2025

Same author

Activating NRF2<sup>E79Q</sup> mutation alters the differentiation of human non-small cell lung cancer.

Cancer gene therapy·2025

Same journal

Respiratory function test in the case of temporary phrenic nerve contusion, associated with pneumoperitoneum; About the diagnostic value of laparoscopy.

Schweizerische medizinische Wochenschrift·2010

Same journal

Treatment of pulmonary tuberculosis and pleurisy by means of temporary paralysis of the diaphragm, supported by the pneumoperitoneum.

Schweizerische medizinische Wochenschrift·2010

Same journal

Boeck's disease as a tuberculous syndrome.

Schweizerische medizinische Wochenschrift·2010

Same journal

Enteral primary tubercular complexes

Schweizerische medizinische Wochenschrift·2010

Same journal

Tuberculous stenoses of the large bronchi.

Schweizerische medizinische Wochenschrift·2010

Same journal

About the enzyme action.

Schweizerische medizinische Wochenschrift·2010

See all related articles

Pseudomembranous enterocolitis, often following antibiotic use, has standard treatments like metronidazole or vancomycin. However, 10-25% of patients experience recurrent Clostridium difficile infections, requiring further therapeutic strategies.

Area of Science:

Gastroenterology
Infectious Diseases
Microbiology

Background:

Pseudomembranous enterocolitis is frequently associated with prior antibiotic administration.
Standard therapeutic options include oral metronidazole or vancomycin.
Recurrence rates for Clostridium difficile enterocolitis range from 10% to 25%.

Observation:

Factors contributing to recurrent Clostridium difficile enterocolitis include endogenous reinfection via spore formation.
Selective deficiencies in IgG1 or IgA may predispose individuals to recurrent infections.
Infection with mutated strains of Clostridium difficile is another identified risk factor.

Findings:

Repeat oral vancomycin in conjunction with Saccharomyces boulardii can be employed for recurrent cases.

Related Experiment Videos

Intravenous immunoglobulin administration is an option for managing severe cases of colitis.

Understanding recurrence factors is crucial for effective management.

Implications:

Novel therapeutic approaches are needed to reduce the high recurrence rates of Clostridium difficile enterocolitis.
Further research into host immune factors and microbial virulence may elucidate new treatment targets.
Optimizing treatment strategies can improve patient outcomes and reduce healthcare burdens.